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ABSTRACT
In medicine, assigning priorities for original ideas
and for first implementation of a new type of treat-
ment or technology—radium afterloading, for ex-
ample—is often difficult. This situation is certainly
true for radium therapy, with conflicting claims com-
ing from France, Germany, and the United States
about who first implemented it. Moreover, if pos-
sible, a distinction must be made between the per-
son who had the idea for a therapy and the person
who actually implemented it. These people are not
always one and the same. Difficulties in assigning
priority also sometimes arise from the lack of a pub-
lished claim in a medical journal, and extant photo-
graphic evidence is typically almost impossible to
find some 100 years after the event. The present ar-
ticle tries to solve the problems of priority regarding
those who were really responsible for the ideas and
implementation of radium therapy, including the
technique of afterloading.
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1. INTRODUCTION
This article investigates priority claims for radium
therapy with the aim of being able to cite literature
sources in answering the following questions:
• Who first had the idea for radium therapy?
• Who first implemented radium therapy for be-
nign skin diseases?
• Who first demonstrated a radium therapy cure
for skin cancer?
• Who first proposed and implemented radium
afterloading?
These questions are not as easy to answer as are
those concerning the dates for the discovery of ra-
dioactivity by Becquerel and of radium by the Curies.
What is even more difficult is to prioritize the use of
radium therapy for specific body sites. Those priori-
ties can usually be only a matter of guesswork from
secondary sources such as textbooks on radiotherapy
in the first decade of the twentieth century. The pri-
mary sources quoted are often in obscure journals
that very few medical libraries possess—or they are
not mentioned at all.
2. X-RAY THERAPY AS A PRECURSOR TO
RADIUM THERAPY
The obvious precursor of radium therapy is X-ray
therapy. Therapy using X-rays for skin conditions and
diseases had already been demonstrated by the end
of the nineteenth century, and unintentional skin burns
had been observed.
Leopold Freund in Vienna is generally accepted
as having been the first to use X-rays logically and
scientifically within the limits of the age. His patient,
a 5-year-old girl with a hairy nevus 36 cm in length,
started treatment on November 24, 1896—X-rays
having been discovered only 12 months earlier, on
November 6, 1895. After successful epilation, an
X-ray ulcer persisted for about 6 years, but it was
considered to be cured in 1902 when only a scar re-
mained. This patient was followed up when she was
75 years of age; apart from back pain, she was found
to be in good health at that time 1–4. This epilatory
effect of X-rays established them as a direct agent
for producing biologic change.
Evidence for the harmful effects of X-rays had
become known within a few months of their discov-
ery. Thomas Edison 5 reported in March 1896 that
his eyes were sore after he experimented with X-rays.
Radiation burns to hands were reported 6 in the Brit-
ish Medical Journal in April 1896; and, in February
1897, in the Bulletin of the Johns Hopkins Hospital,
a review 7 was given of 23 cases of X-ray injury re-
ported in the literature before January 1897. Thus,
by the time of the discoveries in 1898 of polonium 8
and radium 9 by Pierre and Marie Curie, the effects
of X-rays on the skin were well known.
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3. PRIORITY FOR RADIUM SELF-EXPOSURE
EXPERIMENTS
3.1 Germany
The first two reports in the literature 10–12 of self-
exposure experiments showing radium causing skin
burns were made by two Germans, Friedrich Walkoff
and Friedrich Giesel. In October 1900, Giesel de-
scribed in a chemistry journal the strapping of 270 mg
of radium salt to his inner forearm for a duration of
2 hours; he also wrote to inform Pierre Curie about
the experiment. The Walkoff reference of 1900 con-
sisted of just three lines in a three-page general re-
view presented to a photographic club in Munich.
Giesel was the first to prepare radium sources in
Germany for sale by the Buchler company of
Braunschweig (Brunswick). In the first ten years of
the twentieth century, this “German radium” competed
commercially with “French radium,” such as that pre-
pared and sold by Armet de Lisle in Paris. Interest-
ingly, both companies were able to start radium
production at an early date because both were involved
in quinine production. Some of the manufacturing
processes for quinine and radium were similar.
3.2 France
Henri Becquerel’s radium burn was accidental. He
received it after he had placed a radium source inside
his jacket pocket. However, he gave credit 13 for the
first radium burn observations to Friedrich Walkoff
and Friedrich Giesel.
Then, in June 1901, together with Pierre Curie,
Becquerel reported 13 self-exposure measurements
with radium using a source placed many times in “a
pocket of his jacket.” Those experiments have been
described in detail in Current Oncology 12.
3.3 United States
In the very early years following the discovery of
radium, most studies took place in Europe. The United
States and Canada lagged behind because radium
sources were scarce, and no North American sup-
plier had yet emerged. Most of the early sources ob-
tained in the United States were brought back from
Europe by visiting doctors and scientists. However,
by about 1904, the United States was starting to catch
up with Europe, and in Canada, Ernest Rutherford
had commenced work at McGill University in
Montreal.
In the United States, the reports of self-exposure
experiments in 1904 by Robert Abbé, a New York
surgeon, were the most detailed. Abbé performed
radiobiologic experiments in 1904 14, and in 1907,
he published 15 his answer to a friend’s question,
“What difference is there between the light from the
stars and radium rays?”
Abbé’s reply was as follows:
Radium rays move in absolute straight
lines, without deviation by atmosphere, water,
lenses or prisms, and nothing is opaque to
them. They would even penetrate the stone
column in my garden, which light does not.
Using a small glass tube containing a bit of
radium about the size of a grain of rice,
60 milligram pure radium bromide, German,
and an exposure time of three days this is
demonstrated. This same demonstration has
been made by Röntgen rays, but it is far more
impressive to witness the active energy in-
cessantly given off by the innocent looking
little tube of salt.
Abbé varied the exposure to radium in his ex-
periments and correlated it with the degree of
erythema and necrosis produced, publishing his re-
sults in the New York Medical Record 14,16,17.
George H. Stover of Denver, Colorado, was also
among the first American physicians to obtain a sup-
ply of radium, purchasing some radium chloride in
August 1903 from a Paris dealer. He was therefore
one of the first Americans to conduct self-exposure
experiments with radium, as reported in the Colo-
rado Medical Journal:
My own experiments with this substance
are as follows: The chloride of radium is en-
closed in a sealed glass tube. On taking this
tube between the fingers for from three to five
minutes, I felt a distinct heat and tingling.
Applying it to the skin of the forearm: After
five to fifteen minutes the heat and tingling
are felt. After half an hour this is noticed no
longer, and the skin which has been directly
under the tube is distinctly less sensitive to
touch, pain and temperature, than the sur-
rounding skin. After one hour to two hours
there is left a slight erythema, which persists
for some hours. 18
Stover was also a pioneer in the use of X-rays
for diagnosis and therapy and was the first professor
of Roentgenology at the Denver and Gross College
of Medicine, and then of its successor institution,
the University of Colorado School of Medicine. His
early death was the result of excessive radiation
exposure.
4. PRIORITY FOR RADIUM
BRACHYTHERAPY
4.1 France
In 1996, a display cabinet in the Physics Department
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Industrielles (ESPCI) in the rue Vacquelin (formerly in
1898 part of the rue Lhomond) held a small collec-
tion of some of Pierre Curie’s apparatus and lecture
notes. These items dated from when Curie worked at
ESPCI before, during, and after the discoveries of polo-
nium and radium. A page dated November 29 and
December 4 (without any year recorded) gave Pierre’s
measurement of 0.394 g radium sulphate in a rub-
ber-covered capsule for a person named Danlos.
It has been known for many years that Henri
Danlos of the Hôpital St-Louis, Paris, was the first
physician to whom Pierre Curie loaned a source of
radium. The first patient to receive treatment re-
ceived it for lupus rather than for skin cancer, and a
local surface application was reported in 1901 19 by
Henri Danlos and Paul Bloch, but no photographs
were included. However, a photograph of the treat-
ment does exist (Figure 1) and was published in a
1905 book by Charles Baskerville 20. Baskerville
described the dose as 19,000 X-units. This X-unit
measurement was almost certainly the amount of
radioactivity of the source as compared with an equal
weight of uranium.
It should be noted, though, that Henri Danlos was
not the first to have the idea of using radium to treat
skin conditions. Louis Wickham and Paul Degrais,
in the preface to their Radiumtherapy textbook of
1910 21, give the credit to Pierre Curie and to the
Hôpital St-Louis dermatologist Ernest Besnier, who
was 70 years old in 1901. Age would explain why
Besnier did not carry out the treatment; Danlos was
57 years old and not retired. Ernest Besnier had ear-
lier diagnosed Becquerel’s radium burn, which pre-
sumably gave him the idea that radium could be used
to treat lupus 22.
4.2 United States
Danlos and Bloch published their results 19 in Paris
in 1901, but in Boston, William Rollins had, in late
1900, given a radium source to his brother-in-law
Francis Williams to be used for radium therapy.
Francis Williams is therefore perhaps ahead of Henri
Danlos in terms of priority for the clinical use of ra-
dium, even though the Boston results were not effec-
tive. The conditions treated by Williams with his weak
source of radium were not recorded.
In the February 25, 1904, issue of the Boston
Medical and Surgical Journal (the forerunner of the
New England Journal of Medicine), Francis Williams
wrote this:
Dr. William Rollins of Boston was, so far
as I am aware, the first to appreciate that this
new substance would probably be of service
in the treatment of certain diseases. At least
two or three years ago he put into my hands a
metal box with an aluminium front, contain-
ing some chloride of radium, and at his sug-
gestion I employed it for therapeutic
purposes, but the radium to be had at that time
was too weak to give definite results. 23
In 1908, Williams wrote again on the same topic
as in 1904—a comparison between X-rays and ra-
dium—this time publishing in the Journal of the
American Medical Association 24. He begins that
paper with these words:
In 1900 Dr. William Rollins of Boston
suggested the use of the radiations from ra-
dium salts as a therapeutic agent. The salts
then available were not powerful enough to
be efficient. To Dr. Rollins nevertheless, as
far as I am aware, is due the credit of being
the first to realize the probable value of these
radiations as a therapeutic agent.
Williams also stated in his February 1904 paper 23
that he had recently treated 50 patients with pure ra-
dium bromide—usually 50 mg, but on some occa-
sions varying between 10 mg and 100 mg. These
cases consisted of “one [...] of acne, two of psoriasis,
five of lupus vulgaris, two of lupus erythematosus,
two of eczema, one of keloid, five of rodent ulcer, 28
of epidermoid carcinoma and four breast cases.”
4.3 Germany
In Germany, it appears that Hermann Strebel of
Munich might have had priority ahead of Henri
FIGURE 1 Photograph published in 1905 20 by Charles Baskerville,
a chemist and mineralogist of New York. Baskerville described it
as “Dr. Danlos and assistants treating a lupus patient with radium”
and then continued in his text with “Danlos of St-Louis Hospital,
Paris, apparently was the first to apply radium in the treatment of
certain affectations of the skin similar to the treatment with Röntgen
and the ultra-violet rays (Finsen).”MOULD
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Danlos for being the first to use radium clinically,
but as in the case of Francis Williams, the results were
not effective. He also was probably the first to whom
it occurred to actually use radium for therapy, pre-
ceding Ernest Besnier. Strebel’s report 25 in 1903 in
the Deutsche Medizinische Zeitung stated that he
“placed a quantity of radium enclosed in a capsule
made from cardboard and paraffined paper on an area
of lupus and left it in place for hours. A moderate
reaction was obtained with subsequent fading of the
lupus node. With further irradiation an ulcer formed
which healed only poorly, but the lupus was not
healed.” Strebel reasoned that the unsatisfactory re-
sults were attributable to “low radiation capacity of
the radium available.” He then noted that Danlos and
Bloch had announced their successful treatment of
lupus vulgaris after his own unsuccessful attempts.
4.4 Russia
Non-malignant skin conditions such as lupus and
angioma were chosen for treatment before skin can-
cers. Then, in 1903 in St. Petersburg, reporting 26 in
the Dermatologische Zeitschrift, S.W. Goldberg and
Efim Semenovich London claimed the first histologi-
cally proven cure of a basal cell carcinoma of the
face. However, unlike the first documented 27,28 his-
tologic cures from X-rays (also for basal cell carci-
nomas of the face, in 1899 in Stockholm), no
photographs of the radium patient before and after
treatment are known.
5. PRIORITY FOR RADIUM AFTERLOADING
In 1903, Hermann Strebel of Munich was the first
person to propose 25 the use of afterloading, although
Robert Abbé of New York who published in 1906 15
is often given priority for this important radium
brachytherapy technology proposal.
In his report, Strebel comments that the radium
sources available to him in 1903 had a strength of
1.5 million uranium units and were capable of pro-
ducing radiation dermatitis lasting 8–14 days after
an exposure of only 10 minutes. It was to avoid this
problem that he instituted his interstitial afterloading
technique:
I am now in a position to increase the ef-
fectiveness of radium for deeper seated patho-
logical conditions quite significantly, without
causing undesirable effects on the skin itself.
Instead of surface applications, intratumoural
application is carried out by inserting the ra-
dium, which is enclosed in the drilled tip of a
small aluminium rod, directly into the centre
of the tumour, with the help of a previously
inserted trepan. This increases the size of the
irradiation beam in that the radium irradiates
evenly in all directions. 25
Strebel then continued to advocate the trepan
(afterloading guide) needle being inserted in various
directions, always using the first insertion opening,
and he stated that this method is suitable for cancers
of the uterus, stomach, and liver, and “can be used
successfully as a substitute for X-rays when it is a
question of the treatment taking place within small
spaces such as the nose, larynx, and bladder.”
The idea of insertion of the radium within the
trepan needle in various directions is essentially the
idea of crossfire irradiation, although Strebel did not
use that term. It was left to Louis Wickham and Paul
Degrais in 1910 21 to clearly define crossfire. In 1913,
they further described an interstitial technique for the
treatment of an inoperable malignant tumour of the
neck in which they used goose quills as afterloading
guides (Figure 2) 29. They reported that the quills
“allowed introduction of radium tubes deep into tis-
sues at four opposite points of the tumour.”
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